期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Curcumin:reclaiming the lost ground against cancer resistance
1
作者 Siraj Shaikh Javed Shaikh +3 位作者 yusufi sadia naba Kailas Doke Khursheed Ahmed Mujahid yusufi 《Cancer Drug Resistance》 2021年第2期298-320,共23页
Curcumin, a polyphenol, has a wide range of biological properties such as anticancer, antibacterial, antitubercular, cardioprotective and neuroprotective. Moreover, the anti-proliferative activities of Curcumin have b... Curcumin, a polyphenol, has a wide range of biological properties such as anticancer, antibacterial, antitubercular, cardioprotective and neuroprotective. Moreover, the anti-proliferative activities of Curcumin have been widely studied against several types of cancers due to its ability to target multiple pathways in cancer. Although Curcumin exhibited potent anticancer activity, its clinical use is limited due to its poor water solubility and faster metabolism. Hence, there is an immense interest among researchers to develop potent, water-soluble, and metabolically stable Curcumin analogs for cancer treatment. While drug resistance remains a major problem in cancer therapy that renders current chemotherapy ineffective, curcumin has shown promise to overcome the resistance and re-sensitize cancer to chemotherapeutic drugs in many studies. In the present review, we are summarizing the role of curcumin in controlling the proliferation of drug-resistant cancers and development of curcumin-based therapeutic applications from cell culture studies up to clinical trials. 展开更多
关键词 CURCUMIN drug-resistant cancer signaling pathways clinical trials
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部